Ask AI

Shaping the Future of ALL: Advancing Novel Immune-Targeted Therapies to Address Unmet Clinical Needs

Hematologists and oncologists will gain in-depth knowledge on novel T-cell engager therapies, including their mechanism of action, safety, and efficacy, in acute lymphoblastic leukemia and identify patients who may be eligible for enrollment on clinical trials evaluating these immune-targeted therapies through an expert-written ClinicalThought commentary, an on-demand webcast, and downloadable slides. 

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca